Skip to ContentSkip to Navigation
How to find us prof. dr. H.W. (Hans) Nijman


Frozen section diagnosis of borderline ovarian tumors with suspicious features of invasive cancer is a devil's dilemma for the surgeon: A systematic review and meta-analysis

In Vitro Systematic Drug Testing Reveals Carboplatin, Paclitaxel, and Alpelisib as a Potential Novel Combination Treatment for Adult Granulosa Cell Tumors

Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making

Strategies to Target Tumor Immunosuppression

Association of homozygous variants of STING1 with outcome in human cervical cancer

Cervical cancer with ≤5 mm depth of invasion and >7 mm horizontal spread - Is lymph node assessment only required in patients with LVSI?

Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome

Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccine based on recombinant viral particles

Read more


Interview bij ZonMW

Immunoncologie artikel therapeutisch HPV vaccin voor cervixcarcinoom

Kankervaccin klaar voor tests op patiënten